Appreciating the differences between immunoassays used to diagnose maternal parvovirus B19 infection: understanding the antigen before interpreting the results
Author:
- 16 September 2002
- journal article
- Published by Elsevier in Primary Care Update for OB/GYNS
- Vol. 9 (5) , 154-159
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteinsJournal of Medical Virology, 2001
- The VP1-unique region of parvovirus B19: amino acid variability and antigenic stabilityJournal of General Virology, 2001
- Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysisJournal of Virological Methods, 2000
- Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgGJournal of Medical Virology, 1999
- Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19European Journal of Clinical Microbiology & Infectious Diseases, 1996
- Erythrocyte P Antigen: Cellular Receptor for B19 ParvovirusScience, 1993
- Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.Proceedings of the National Academy of Sciences, 1991
- Experimental Parvoviral Infection in HumansThe Journal of Infectious Diseases, 1985
- Characterization and Molecular Cloning of a Human Parvovirus GenomeScience, 1984
- PARVOVIRUS-LIKE PARTICLES IN HUMAN SERAThe Lancet, 1975